Hydrocortisone Hualan Pharmaceuticals (Hydrocortisone)

Hydrocortisone Hualan Pharmaceuticals is indicated for several endocrine and inflammatory conditions that benefit from systemic glucocorticoid therapy.

• Replacement therapy for primary or secondary adrenal insufficiency (e.g., Addison's disease)
• Management of congenital adrenal hyperplasia
• Treatment of acute inflammatory episodes in autoimmune disorders such as systemic lupus erythematosus
• Adjunctive therapy for severe allergic reactions
• Short‑term control of flare‑ups in chronic inflammatory diseases like rheumatoid arthritis

• Hydrocortisone acts as an agonist at intracellular glucocorticoid receptors, forming a hormone‑receptor complex that translocates to the nucleus. This complex binds glucocorticoid response elements on DNA, modulating transcription of anti‑inflammatory proteins and suppressing pro‑inflammatory cytokine genes, thereby reducing inflammation and altering immune cell activity.

Hydrocortisone Hualan Pharmaceuticals may cause a range of adverse reactions, varying in frequency and severity.

Common

• Increased appetite or weight gain
• Mild gastrointestinal discomfort
• Fluid retention leading to peripheral edema
• Mood changes such as irritability or euphoria
• Elevated blood glucose levels
• Skin thinning or easy bruising

Serious

• Severe infection due to immunosuppression
• Adrenal crisis on abrupt discontinuation
• Osteoporosis or pathological fractures
• Peptic ulcer disease with gastrointestinal bleeding
• Psychiatric disturbances including psychosis
• Hyperglycemic emergencies in diabetic patients

Before initiating therapy with Hydrocortisone Hualan Pharmaceuticals, consider the following safety points.

• Assess for active infections; glucocorticoids can exacerbate bacterial, viral, or fungal infections.
• Evaluate bone health, especially in long‑term use, due to risk of osteoporosis.
• Monitor blood glucose in patients with diabetes or risk factors for hyperglycemia.
• Use the lowest effective dose for the shortest duration to limit systemic side effects.
• Counsel patients on gradual tapering to avoid adrenal insufficiency.
• Review vaccination status; live vaccines are contraindicated during systemic glucocorticoid therapy.
• Exercise caution in pregnancy; the safety profile is not well established.

Hydrocortisone Hualan Pharmaceuticals can interact with several drug classes; awareness helps prevent adverse outcomes.

Avoid

• Strong CYP3A4 inducers (e.g., rifampin, phenytoin) that may reduce hydrocortisone plasma levels.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) that increase risk of gastrointestinal ulceration and bleeding.
• Anticoagulants such as warfarin, where glucocorticoids may enhance anticoagulant effect.

Use with caution

• Antidiabetic agents, as hydrocortisone may raise blood glucose and require dose adjustments.
• Antihypertensive medications, particularly ACE inhibitors or diuretics, due to potential fluid retention.
• Vaccines, especially live attenuated vaccines, because immunosuppression can diminish efficacy.
• Other systemic steroids, which may increase cumulative glucocorticoid exposure.
• Antifungal azoles (e.g., ketoconazole) that can inhibit steroid metabolism and raise systemic levels.